Cell therapy is a promising option for the treatment of ischemic diseases. Infusion or injection of stem or progenitor cells has improved neovascularization and heart function after ischemia in ...

A medical device company developing technology to improve outcomes for stroke patients will begin enrollment for a new ...

Learn about atorvastatin-loaded PEGylated liposomes as a targeted therapeutic approach for treating ischemic stroke, focusing ...

The ReoPro Retavase Reperfusion of Stroke Safety Study (ROSIE) is an NIH-sponsored Phase II trial evaluating intravenous reteplase in combination with abciximab for the treatment of patients with ...

Inretio presents initial clinical trial results at prestigious BRAIN Conference 2024 in London.Toronto, Ontario--(Newsfile Corp. - December 11, ...

A machine learning model for analysing brain lesion scans after stroke could mean up to 50% more patients receive appropriate ...

Hepatic ischemia-reperfusion injury (HIRI) is a key factor leading to complications and poor prognosis after hepatobiliary surgery, but its pathogenesis remains unclear. Hence, it is a very necessary ...

On November 2, 2024, Simcere Pharmaceutical announced that Sanbexin® sublingual tablets (generic name: edaravone and ...